He was joined on Capitol Hill by Olympian Dotsie Bausch, and she stated, “In the name of social and educational justice, we now urge our leaders in the Congress to amend the Richard B.

Przedstawiona nam zostaje Dotsie Bausch – amerykańska kolarka torowa, która największe sukcesy (olimpijskie medale!) zaczęła osiągać jak na tę dyscyplinę sportową bardzo późno ...

WASHINGTON—Two Olympians are competing to influence federal nutrition policy on a question for Americans’ breakfast tables: Does milk do a body good? In one corner is Olympic cyclist Dotsie ...

Monday was an eventful day for Bausch + Lomb (NYSE: BLCO). The eye care specialist's major piece of internal news was that it earned its latest Food and Drug Administration (FDA) approval.

Bausch Health turned down recent debt-restructuring proposals from bondholders as it explores a sale of its Bausch + Lomb vision care subsidiary that could bring in billions of dollars to pay ...

Bausch + Lomb shares surged Monday following reports Blackstone and TPG are considering teaming up to buy the eyecare company. A bid from Blackstone and TPG could reportedly value the company ...

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products.

Bausch Health Companies Inc. (NYSE:BHC) shareholders should be happy to see the share price up 26% in the last month. But that is meagre solace in the face of the shocking decline over three years ...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

It isn't known whether Bausch + Lomb and/or Goldman is in contact with either Blackstone or TPG. According to the FT, several private equity funds mulling offers have dropped out of the race.